Canada Enteral Nutrition Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Disease Indication (Orthopedic Disorders, Cardiovascular Disorders, Oncology, Neurological Disorders, and Others), Formula Type (Standard Formulas, Peptide Formulas, and Specialized Formulas), Route of Administration (Oral and Tube Feed), and End User (Long Term Care Facilities, Hospitals, and Others)
The Canada enteral nutrition market size is expected to grow from CA$ 514.33 million in 2023 to CA$ 817.11 million by 2031; it is estimated to register a CAGR of 6.0% from 2022 to 2030.
Use of Next-Generation Technologies to Ensure Proper Feeding Routines Will Provide Opportunity for Growth of Canada enteral nutrition market
In enteral feeding, it is important to calculate the daily and cumulative energy balance of patients, which helps doctors tailor the feeding routing according to their needs and decreases morbidity and mortality risks. It is also essential to maintain the nutrient supply after discharge. No proper technology or equipment is available for calculating patients’ daily and cumulative energy balance. Researchers are now focusing on using artificial intelligence (AI) and prediction algorithms to develop technology that can be used to handle caloric and protein deficits and monitor the energy balance. The next-generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy levels and nutrient (proteins and vitamins) deficits. A similar approach could help tackle deficit challenges in the post-ICU period. The implementation of next-generation technology-based tools in critical stages could help to ensure constant measurement, monitoring, and achievement of the nutritional plan and goals. In addition, data collected by wearable devices, including data from sensors continuously measuring physical activity and glucose levels, can be integrated with electronic health records (EHR).
The growing fields of metabolomics and proteomics hold the potential to enable the assessment of nutritional status, determining the appropriate adjustments of nutrient mix, and monitoring progress through various stages of illness. Therefore, the use of AI, predictive analytics, metabolomics and proteomics, and several other next-generation technologies ensuring proper feeding routines are expected to create lucrative growth opportunities for the Canada enteral nutrition market during the forecast period.
Disease Indication -Based Insights
Based on disease indication, the orthopedic disorders segment held the largest Canada enteral nutrition market share in 2023. The Cardiovascular disorders segment is anticipated to register the highest CAGR during 2023–2031.
?
Formula Type -Based Insights
Based on formula type, the companion animals segment held a larger market share in 2023. The standard formulas segment is anticipated to register a higher CAGR from 2023 to 2031 and the same segment held a larger Canada enteral nutrition market share.
Route Of Administration -Based Insights
Based on route of administration, the oral segment held a larger share of the Canada enteral nutrition market in 2023 and the same segment is anticipated to register a higher CAGR during 2023–2031.
End User -Based Insights
In terms of end user, the long-term care facilities segment is anticipated to account for a significant market share during 2023–2031.
A few of the major primary and secondary sources referred to while preparing the report on the Canada enteral nutrition market are the Food And Drug Administration, International Diabetes Federation, National Center for Biotechnology Information.
Use of Next-Generation Technologies to Ensure Proper Feeding Routines Will Provide Opportunity for Growth of Canada enteral nutrition market
In enteral feeding, it is important to calculate the daily and cumulative energy balance of patients, which helps doctors tailor the feeding routing according to their needs and decreases morbidity and mortality risks. It is also essential to maintain the nutrient supply after discharge. No proper technology or equipment is available for calculating patients’ daily and cumulative energy balance. Researchers are now focusing on using artificial intelligence (AI) and prediction algorithms to develop technology that can be used to handle caloric and protein deficits and monitor the energy balance. The next-generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy levels and nutrient (proteins and vitamins) deficits. A similar approach could help tackle deficit challenges in the post-ICU period. The implementation of next-generation technology-based tools in critical stages could help to ensure constant measurement, monitoring, and achievement of the nutritional plan and goals. In addition, data collected by wearable devices, including data from sensors continuously measuring physical activity and glucose levels, can be integrated with electronic health records (EHR).
The growing fields of metabolomics and proteomics hold the potential to enable the assessment of nutritional status, determining the appropriate adjustments of nutrient mix, and monitoring progress through various stages of illness. Therefore, the use of AI, predictive analytics, metabolomics and proteomics, and several other next-generation technologies ensuring proper feeding routines are expected to create lucrative growth opportunities for the Canada enteral nutrition market during the forecast period.
Disease Indication -Based Insights
Based on disease indication, the orthopedic disorders segment held the largest Canada enteral nutrition market share in 2023. The Cardiovascular disorders segment is anticipated to register the highest CAGR during 2023–2031.
?
Formula Type -Based Insights
Based on formula type, the companion animals segment held a larger market share in 2023. The standard formulas segment is anticipated to register a higher CAGR from 2023 to 2031 and the same segment held a larger Canada enteral nutrition market share.
Route Of Administration -Based Insights
Based on route of administration, the oral segment held a larger share of the Canada enteral nutrition market in 2023 and the same segment is anticipated to register a higher CAGR during 2023–2031.
End User -Based Insights
In terms of end user, the long-term care facilities segment is anticipated to account for a significant market share during 2023–2031.
A few of the major primary and secondary sources referred to while preparing the report on the Canada enteral nutrition market are the Food And Drug Administration, International Diabetes Federation, National Center for Biotechnology Information.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. CANADA ENTERAL NUTRITION MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Geriatric Patient Population Specific Analysis
5. CANADA ENTERAL NUTRITION MARKET – KEY MARKET DYNAMICS
5.1 Canada Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surge in Prevalence of Cachexia and Related Disorders
5.2.2 Rise in Prevalence of Gastrointestinal Diseases
5.3 Market Restraints
5.3.1 Complications Associated with Enteral Nutrition
5.4 Market Opportunities
5.4.1 Use of Next-Generation Technologies to Ensure Proper Feeding Routines
5.5 Future Trends
5.5.1 Specific Formulations and Plant-Based Nutrition Products
6. CANADA ENTERAL NUTRITION MARKET ANALYSIS
6.1 Canada Enteral Nutrition Market Revenue Forecast and Analysis (CA$ Million), 2023–2031
7. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY DISEASE INDICATION
7.1 Orthopedic Disorders
7.1.1 Overview
7.1.2 Orthopedic Disorders: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.2 Cardiovascular Disorders
7.2.1 Overview
7.2.2 Cardiovascular Disorders: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.4 Neurological Disorders
7.4.1 Overview
7.4.2 Neurological Disorders: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
8. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY FORMULA TYPE
8.1 Standard Formulas
8.1.1 Overview
8.1.2 Standard Formulas: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
8.2 Peptide Formulas
8.2.1 Overview
8.2.2 Peptide Formulas: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
8.3 Specialized Formulas
8.3.1 Overview
8.3.2 Specialized Formulas: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
9. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
9.2 Tube Feed
9.2.1 Overview
9.2.2 Tube Feed: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
10. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY END USER
10.1 Long Term Care Facilities
10.1.1 Overview
10.1.2 Long Term Care Facilities: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
11. COMPANY PROFILES
11.1 Nestle SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott Laboratories
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Fresenius Medical Care AG & Co KGaA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Koninklijke DSM NV
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 B Braun SE
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. APPENDIX
12.1 About The Insight Partners
12.2 Glossary of Terms in Canada Enteral Nutrition Market
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. CANADA ENTERAL NUTRITION MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Geriatric Patient Population Specific Analysis
5. CANADA ENTERAL NUTRITION MARKET – KEY MARKET DYNAMICS
5.1 Canada Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surge in Prevalence of Cachexia and Related Disorders
5.2.2 Rise in Prevalence of Gastrointestinal Diseases
5.3 Market Restraints
5.3.1 Complications Associated with Enteral Nutrition
5.4 Market Opportunities
5.4.1 Use of Next-Generation Technologies to Ensure Proper Feeding Routines
5.5 Future Trends
5.5.1 Specific Formulations and Plant-Based Nutrition Products
6. CANADA ENTERAL NUTRITION MARKET ANALYSIS
6.1 Canada Enteral Nutrition Market Revenue Forecast and Analysis (CA$ Million), 2023–2031
7. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY DISEASE INDICATION
7.1 Orthopedic Disorders
7.1.1 Overview
7.1.2 Orthopedic Disorders: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.2 Cardiovascular Disorders
7.2.1 Overview
7.2.2 Cardiovascular Disorders: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.4 Neurological Disorders
7.4.1 Overview
7.4.2 Neurological Disorders: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
8. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY FORMULA TYPE
8.1 Standard Formulas
8.1.1 Overview
8.1.2 Standard Formulas: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
8.2 Peptide Formulas
8.2.1 Overview
8.2.2 Peptide Formulas: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
8.3 Specialized Formulas
8.3.1 Overview
8.3.2 Specialized Formulas: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
9. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
9.2 Tube Feed
9.2.1 Overview
9.2.2 Tube Feed: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
10. CANADA ENTERAL NUTRITION MARKET ANALYSIS – BY END USER
10.1 Long Term Care Facilities
10.1.1 Overview
10.1.2 Long Term Care Facilities: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (CA$ Million)
11. COMPANY PROFILES
11.1 Nestle SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott Laboratories
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Fresenius Medical Care AG & Co KGaA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Koninklijke DSM NV
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 B Braun SE
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. APPENDIX
12.1 About The Insight Partners
12.2 Glossary of Terms in Canada Enteral Nutrition Market
